844 related articles for article (PubMed ID: 12921534)
1. Characterization of the anti-apoptotic mechanism of Bcl-B.
Zhai D; Ke N; Zhang H; Ladror U; Joseph M; Eichinger A; Godzik A; Ng SC; Reed JC
Biochem J; 2003 Nov; 376(Pt 1):229-36. PubMed ID: 12921534
[TBL] [Abstract][Full Text] [Related]
2. Structure-function analysis of Bcl-2 family proteins. Regulators of programmed cell death.
Reed JC; Zha H; Aime-Sempe C; Takayama S; Wang HG
Adv Exp Med Biol; 1996; 406():99-112. PubMed ID: 8910675
[TBL] [Abstract][Full Text] [Related]
3. Induction of apoptosis in prostate carcinoma cells by BH3 peptides which inhibit Bak/Bcl-2 interactions.
Finnegan NM; Curtin JF; Prevost G; Morgan B; Cotter TG
Br J Cancer; 2001 Jul; 85(1):115-21. PubMed ID: 11437412
[TBL] [Abstract][Full Text] [Related]
4. Differential regulation of Bax and Bak by anti-apoptotic Bcl-2 family proteins Bcl-B and Mcl-1.
Zhai D; Jin C; Huang Z; Satterthwait AC; Reed JC
J Biol Chem; 2008 Apr; 283(15):9580-6. PubMed ID: 18178565
[TBL] [Abstract][Full Text] [Related]
5. Structural biology of the Bcl-2 family of proteins.
Petros AM; Olejniczak ET; Fesik SW
Biochim Biophys Acta; 2004 Mar; 1644(2-3):83-94. PubMed ID: 14996493
[TBL] [Abstract][Full Text] [Related]
6. Minimal BH3 peptides promote cell death by antagonizing anti-apoptotic proteins.
Moreau C; Cartron PF; Hunt A; Meflah K; Green DR; Evan G; Vallette FM; Juin P
J Biol Chem; 2003 May; 278(21):19426-35. PubMed ID: 12642586
[TBL] [Abstract][Full Text] [Related]
7. Interaction of E1B 19K with Bax is required to block Bax-induced loss of mitochondrial membrane potential and apoptosis.
Han J; Modha D; White E
Oncogene; 1998 Dec; 17(23):2993-3005. PubMed ID: 9881701
[TBL] [Abstract][Full Text] [Related]
8. Functional identification of the apoptosis effector BH3 domain in cellular protein BNIP1.
Yasuda M; Chinnadurai G
Oncogene; 2000 May; 19(19):2363-7. PubMed ID: 10822388
[TBL] [Abstract][Full Text] [Related]
9. Apoptosis initiated when BH3 ligands engage multiple Bcl-2 homologs, not Bax or Bak.
Willis SN; Fletcher JI; Kaufmann T; van Delft MF; Chen L; Czabotar PE; Ierino H; Lee EF; Fairlie WD; Bouillet P; Strasser A; Kluck RM; Adams JM; Huang DC
Science; 2007 Feb; 315(5813):856-9. PubMed ID: 17289999
[TBL] [Abstract][Full Text] [Related]
10. The conserved N-terminal BH4 domain of Bcl-2 homologues is essential for inhibition of apoptosis and interaction with CED-4.
Huang DC; Adams JM; Cory S
EMBO J; 1998 Feb; 17(4):1029-39. PubMed ID: 9463381
[TBL] [Abstract][Full Text] [Related]
11. Bcl-B, a novel Bcl-2 family member that differentially binds and regulates Bax and Bak.
Ke N; Godzik A; Reed JC
J Biol Chem; 2001 Apr; 276(16):12481-4. PubMed ID: 11278245
[TBL] [Abstract][Full Text] [Related]
12. Contribution of BH3-domain and Transmembrane-domain to the Activity and Interaction of the Pore-forming Bcl-2 Proteins Bok, Bak, and Bax.
Stehle D; Grimm M; Einsele-Scholz S; Ladwig F; Johänning J; Fischer G; Gillissen B; Schulze-Osthoff K; Essmann F
Sci Rep; 2018 Aug; 8(1):12434. PubMed ID: 30127460
[TBL] [Abstract][Full Text] [Related]
13. Survival activity of Bcl-2 homologs Bcl-w and A1 only partially correlates with their ability to bind pro-apoptotic family members.
Holmgreen SP; Huang DC; Adams JM; Cory S
Cell Death Differ; 1999 Jun; 6(6):525-32. PubMed ID: 10381646
[TBL] [Abstract][Full Text] [Related]
14. BH3-only proteins that bind pro-survival Bcl-2 family members fail to induce apoptosis in the absence of Bax and Bak.
Zong WX; Lindsten T; Ross AJ; MacGregor GR; Thompson CB
Genes Dev; 2001 Jun; 15(12):1481-6. PubMed ID: 11410528
[TBL] [Abstract][Full Text] [Related]
15. A splicing variant of the Bcl-2 member Bok with a truncated BH3 domain induces apoptosis but does not dimerize with antiapoptotic Bcl-2 proteins in vitro.
Hsu SY; Hsueh AJ
J Biol Chem; 1998 Nov; 273(46):30139-46. PubMed ID: 9804769
[TBL] [Abstract][Full Text] [Related]
16. Anti-apoptotic Bcl-XL protein in complex with BH3 peptides of pro-apoptotic Bak, Bad, and Bim proteins: comparative molecular dynamics simulations.
Lama D; Sankararamakrishnan R
Proteins; 2008 Nov; 73(2):492-514. PubMed ID: 18452209
[TBL] [Abstract][Full Text] [Related]
17. BID: a novel BH3 domain-only death agonist.
Wang K; Yin XM; Chao DT; Milliman CL; Korsmeyer SJ
Genes Dev; 1996 Nov; 10(22):2859-69. PubMed ID: 8918887
[TBL] [Abstract][Full Text] [Related]
18. Regulation of apoptosis by BH3 domains in a cell-free system.
Cosulich SC; Worrall V; Hedge PJ; Green S; Clarke PR
Curr Biol; 1997 Dec; 7(12):913-20. PubMed ID: 9382837
[TBL] [Abstract][Full Text] [Related]
19. BH3 domains other than Bim and Bid can directly activate Bax/Bak.
Du H; Wolf J; Schafer B; Moldoveanu T; Chipuk JE; Kuwana T
J Biol Chem; 2011 Jan; 286(1):491-501. PubMed ID: 21041309
[TBL] [Abstract][Full Text] [Related]
20. MAP-1, a novel proapoptotic protein containing a BH3-like motif that associates with Bax through its Bcl-2 homology domains.
Tan KO; Tan KM; Chan SL; Yee KS; Bevort M; Ang KC; Yu VC
J Biol Chem; 2001 Jan; 276(4):2802-7. PubMed ID: 11060313
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
